Consero Group, an international leader in hosting high-level, invitation-only events for senior executives, announced today that it will hold its IP Forum For Life Sciences on December 4–6, 2016, at Rancho Bernardo in San Diego, CA. The upcoming forum will examine integrating IP into corporate strategy, protecting the IP portfolio, and navigating industry trade secrets.
“As the IP landscape within the life sciences continues to evolve, IP executives must pursue innovative paths both to protect their global IP portfolios and to manage costs,” said Paul Mandell, Founder and CEO of Consero. “This event will explore ways for chief IP counsel of the life sciences to remain abreast of worldwide IP developments, while maintaining an effective IP management strategy.”
Featured speakers include, among others: Bryan Zielinski of Pfizer, Inc., Bernie Greenspan of Prometheus Laboratories Inc., Paul Lee of DexCom, and Christine McCormack of Novartis.
Additional topics will include:
Founded in 2010, Consero Group is an international leader in creating function-specific events for senior-level executives in industries that include Legal, Compliance, Shared Services, Customer Experience, Finance, IT, HR and Procurement, among others. Based in Bethesda, Maryland, Consero is best known for transforming the executive experience through intimate, invitation-only programs in a sophisticated learning environment with high-level content. For more information on Consero, please visit www.consero.com.